Skip to content

Risk factors for adverse cardiovascular events in liver transplantation

Risk factors associated with adverse cardiovascular events during orthotopic liver transplantation and during early posttransplant time

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ISRCTN
Registry ID
ISRCTN16660149
Enrollment
205
Registered
2025-02-06
Start date
2015-08-10
Completion date
Unknown
Last updated
2026-03-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adverse cardiovascular events in patients eligible for liver transplantation during the procedure itself and early posttransplant time Circulatory System

Interventions

Medical records of patients admitted for liver transplantation and their intraoperative and postoperative charts are examined. Donor data are acquired from Eurotransplant donor reports. Any subsequent

Sponsors

Klinicka bolnica Merkur
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Patients admitted and undergoing liver transplantation in UH Merkur, Zagreb, Croatia 2. 18 years of age and older

Exclusion criteria

Exclusion criteria: 1. Age less than 18 years 2. Liver re-transplantation 3. Acute liver failure 4. Living donor liver transplantation 5. Multiorgan transplantation

Design outcomes

Primary

MeasureTime frame
To establish the incidence of adverse cardiovascular events in a group of patients with liver transplantation during the transplant procedure and early posttransplant time (30 days) measured using data collected from patient medical records at one time point

Secondary

MeasureTime frame
The following secondary outcome measures are evaluated measured using data collected from patient medical records at one time point: 1. Donor and recipient characteristics in a subgroup of patients with severe adverse cardiovascular events 2. The risk of adverse cardiovascular complications in the subgroup of patients with severe adverse cardiovascular events defined using a simple grading scale 3. To create a simple scale based on donor and recipient characteristics, used for risk assessment

Countries

Croatia

Contacts

Public ContactNataša;Nataša Viškovic Filipcic;Viškovic Filipcic

;

natasa.viskovic-filipcic@agram-bolnica.hr;natashav7@gmail.com+385 0913355998;+385 0913355998

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 3, 2026